Merck Serono Creates New Immuno-Oncology Platform
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Merck Serono has set up a dedicated R&D unit to seek out new therapies that stimulate a patient's own immune system to fight cancer. The company said the new unit would complement its established work in oncology by bringing together research, early development work and biomarker strategies for immunological therapies. The unit will focus on three main areas of research, namely the development of therapeutic cancer vaccines, targeting cancer stem cell to stop tumours forming or spreading, and eliminating or circumventing inhibitory mechanisms in the immune system that prevent cancer cells from being recognised and attacked by the body.
Help employers find you! Check out all the jobs and post your resume.
Merck Serono has set up a dedicated R&D unit to seek out new therapies that stimulate a patient's own immune system to fight cancer. The company said the new unit would complement its established work in oncology by bringing together research, early development work and biomarker strategies for immunological therapies. The unit will focus on three main areas of research, namely the development of therapeutic cancer vaccines, targeting cancer stem cell to stop tumours forming or spreading, and eliminating or circumventing inhibitory mechanisms in the immune system that prevent cancer cells from being recognised and attacked by the body.
Help employers find you! Check out all the jobs and post your resume.